Products for Research Use Only
RegisterLogin

CDK2-IN-49

CAT: 0804-HY-179161Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-179161Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK2-IN-49 (Compound 5j) is a CDK2 inhibitor with an IC50 of 0.25 μM. CDK2-IN-49 shows potent activity against CDK7 with an IC50 of 0.14 μM. CDK2-IN-49 induces Apoptosis by raising the levels of p53 and Bax protein expression while reducing the amount of Bcl-2. CDK2-IN-49 inhibits cell division. CDK2-IN-49 can be used in the research of cancer[1].
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; CDK; MDM-2/p53
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
COC1=CC=C(C=C1)/N=N/C2=C3N=CC=C(N3N=C2N)C4=CC=C(C=C4)C
Molecular Formula
C20H18N6O
Molecular Weight
358.40
References & Citations
[1]Elbakry O M, et al. Targeting CDK2 and CDK7: rational design of pyrazolo [1, 5-a] pyrimidine derivatives as potent anticancer agents. New Journal of Chemistry, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P0235CDK2
HY-134622-01GSK-3/CDK5/CDK2-IN-1
HY-179536KRAS-IN-49
HY-163249HSD17B13-IN-49
HY-169156HDAC6-IN-49
HY-157117ICMT-IN-49
HY-161917HPK1-IN-49
HY-168089NLRP3-IN-49
HY-161058AChE-IN-49
HY-120436RM 49

Alternative Products

CatalogName
C07088-100mgCDK2-IN-73 (CDK2-IN-4)
521331-01CDK2

Popular Products